Literature DB >> 32683984

Value in Healthcare Initiative: Summary and Key Recommendations.

Karen E Joynt Maddox1, William K Bleser2, Sandeep R Das3, Nihar R Desai4, Jackie Ng-Osorio5, Emily O'Brien6, Mitchell A Psotka7, Rishi K Wadhera8, William S Weintraub9, Madeleine Konig10.   

Abstract

In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. Following the summit and recognizing the collective momentum it created, the American Heart Association, in collaboration with the Robert J. Margolis Center for Health Policy at Duke University, launched the Value in Healthcare Initiative-Transforming Cardiovascular Care. Four areas of focus were identified, and learning collaboratives were established and proceeded to conduct concrete, actionable problem solving in 4 high-impact areas in cardiovascular care: Value-Based Models, Partnering with Regulators, Predict and Prevent, and Prior Authorization. The deliverables from these groups are being disseminated in 4 stand-alone articles, and their publication will initiate further work to test and evaluate each of these promising areas of reform. This article provides an overview of the initiative's findings and highlights key cross-cutting themes for consideration as the initiative moves forward.

Entities:  

Keywords:  American Heart Association; cardiovascular disease; leadership; quality; value

Mesh:

Year:  2020        PMID: 32683984     DOI: 10.1161/CIRCOUTCOMES.120.006612

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  1 in total

1.  Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug-Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians.

Authors:  Czarlota Valdenor; Divya Ganesan; David Paculdo; Joshua Schrecker; Rebecca Heltsley; Christopher Westerfield; John W Peabody
Journal:  Int J Clin Pract       Date:  2022-07-30       Impact factor: 3.149

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.